Subscribe to RSS
DOI: 10.1055/s-0040-1705364
Short and Long-Term Outcomes of Venoarterial ECMO for the Treatment of Perioperative Cardiogenic Shock in 576 Patients undergoing Cardiac Surgery
Publication History
Publication Date:
13 February 2020 (online)
Objectives: The aim of this study was to analyze short- and long-term outcomes in patients who were treated with venoarterial extracorporeal membrane oxygenation (vaECMO) for treatment of perioperative low-output syndrome (LOS) and identify risk factors for in-hospital mortality.
Methods: All consecutive patients who received vaECMO during or after cardiac surgery at a high-volume center between January 2008 and December 2017 were identified. This patient cohort was characterized and long-term survival (9 years) was analyzed. Furthermore, a regression analysis was performed to identify risk factors for in-hospital mortality.
Results: A total of 576 patients were treated with vaECMO. The mean age was 65 ± 12 years and 37.2% were female. Also, 46.9% underwent elective surgery. Patients underwent isolated coronary bypass in 21.5%, aortic valve replacement in 7.3%, mitral valve replacement or repair in 5%, tricuspid replacement or repair in 2.2%, and heart transplantation in 13%. The median logistic EuroSCORE was 23.9% (IQR: 10.3–46.2). vaECMO was implanted peripherally through femoral vessels in 56.4% and centrally in 34.9%. Again, 43% could be weaned off vaECMO, while 4.6% were switched to a durable ventricular assist device and 0.4% underwent heart transplantation. In 42%, treatment was terminated at the time of vaECMO explantation. In-hospital and 1-year mortality were 66 and 79.9%, respectively. In univariable analysis, age, severe aortic valve stenosis, and EuroSCORE II emerged as risk factors for in-hospital mortality. After multivariable adjustment, age, and EuroSCORE II persisted as independent risk factors for in-hospital mortality. Estimated 9-year survival was 8%. For patients who were discharged alive, estimated 9-year survival was 24.8%.
Conclusion: After treatment of perioperative LOS using vaECMO, 34% of patients could be discharged alive. Overall, in-hospital and long-term mortality were high but acceptable for patients who survived the in-hospital period. In multivariable regression, we found age and EuroSCORE II to be associated with in-hospital death but could not identify more specific risk factors.